uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QURE uniQure N.V.

未开盘 07-22 16:00:00 EDT

7.63

-0.11

-1.49%

盘后7.60

-0.03-0.33%

19:33 EDT

最高7.81	最低7.26	成交量135.32万
今开7.72	昨收7.74	日振幅7.11%
总市值3.70亿	流通市值3.04亿	总股本4,855万
成交额1,017万	换手率3.39%	流通股本3,992万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"QURE","market":"US","secType":"STK","nameCN":"uniQure N.V.","latestPrice":7.625,"timestamp":1721678400000,"preClose":7.74,"halted":0,"volume":1353231,"hourTrading":{"tag":"盘后","latestPrice":7.6,"preClose":7.625,"latestTime":"19:33 EDT","volume":9947,"amount":75697.7702,"timestamp":1721691206735},"delay":0,"floatShares":39924556,"shares":48549437,"eps":-6.197562,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.115,"latestTime":"07-22 16:00:00 EDT","open":7.72,"high":7.81,"low":7.26,"amount":10174361.3230545,"amplitude":0.071059,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.197562,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721721600000},"adr":0,"listingDate":1391576400000,"adjPreClose":7.74,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.69,"preClose":7.74,"latestTime":"09:27 EDT","volume":780,"amount":5970.409925999999,"timestamp":1721654870015},"postHourTrading":{"tag":"盘后","latestPrice":7.6,"preClose":7.625,"latestTime":"19:33 EDT","volume":9947,"amount":75697.7702,"timestamp":1721691206735},"volumeRatio":0.493169,"impliedVol":0.8995,"impliedVolPercentile":0.6972},"requestUrl":"/m/hq/s/QURE/tweets","defaultTab":"tweets","newsList":[{"id":"2453792422","title":"Uniqure N.V.盘中异动 临近午盘大幅跳水5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453792422","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453792422?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:36","pubTimestamp":1721662606,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日23时36分，Uniqure N.V.股票出现异动，股价快速下挫5.30%。截至发稿，该股报7.33美元/股，成交量62.2642万股，换手率1.28%，振幅5.81%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.37%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722233646aefacd0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722233646aefacd0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2452380437","title":"Uniqure N.V.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452380437","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452380437?lang=zh_cn&edition=full","pubTime":"2024-07-19 01:25","pubTimestamp":1721323528,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日01时25分，Uniqure N.V.股票出现波动，股价急速跳水5.08%。截至发稿，该股报8.04美元/股，成交量125.636万股，换手率2.59%，振幅6.73%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为1.51%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719012528aefa5b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719012528aefa5b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2452157120","title":"Uniqure N.V.盘中异动 快速上涨6.51%报9.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452157120","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452157120?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:52","pubTimestamp":1721224327,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时52分，Uniqure N.V.股票出现异动，股价大幅上涨6.51%。截至发稿，该股报9.81美元/股，成交量27.6587万股，换手率0.57%，振幅7.71%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为1.51%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717215207aefa25f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717215207aefa25f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2450536835","title":"Uniqure N.V.盘中异动 早盘急速拉升5.05%报9.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450536835","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450536835?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:31","pubTimestamp":1720791077,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时31分，Uniqure N.V.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报9.36美元/股，成交量12.8489万股，换手率0.26%，振幅1.91%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.61%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。富国集团分析师Yanan Zhu维持持有评级，维持目标价14美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213118aef97a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213118aef97a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2450368113","title":"Uniqure N.V.盘中异动 快速上涨5.14%报10.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450368113","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450368113?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:32","pubTimestamp":1720704759,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时32分，Uniqure N.V.股票出现异动，股价快速拉升5.14%。截至发稿，该股报10.64美元/股，成交量57.6805万股，换手率1.19%，振幅4.15%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.01%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。富国集团分析师Yanan Zhu维持持有评级，维持目标价14美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213240af91dd47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213240af91dd47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2450423818","title":"Uniqure N.V.盘中异动 大幅上涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450423818","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450423818?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:31","pubTimestamp":1720618279,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时31分，Uniqure N.V.股票出现异动，股价大幅拉升6.00%。截至发稿，该股报7.07美元/股，成交量60.8981万股，换手率1.25%，振幅4.62%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.12%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。消息层面，截至21时31分，《一图速览uniQure NV今日评级，最高看至25美元》资讯为影响Uniqure N.V.的重要信息。富国集团分析师Yanan Zhu维持持有评级，维持目标价14美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102131199681b889&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102131199681b889&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4139","LGVN","QURE","BK4007"],"gpt_icon":0},{"id":"2450316028","title":"Uniqure N.V.股价拉升56.69% 市值涨1.63亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450316028","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450316028?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:31","pubTimestamp":1720531886,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时31分，Uniqure N.V.股票出现波动，股价大幅上涨56.69%。截至发稿，该股报5.92美元/股，成交量887.464万股，换手率18.28%，振幅17.03%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Soligenix, Inc.、Anew Medical, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2726.08%、90.13%、80.25%，振幅较大的相关个股有Soligenix, Inc.、Uniqure N.V.、Anew Medical, Inc.，振幅分别为25.99%、17.03%、11.72%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092131269f25b515&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092131269f25b515&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2448152017","title":"Uniqure N.V.盘中异动 急速下跌5.51%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448152017","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448152017?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:44","pubTimestamp":1719927874,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日21时44分，Uniqure N.V.股票出现波动，股价快速下挫5.51%。截至发稿，该股报4.20美元/股，成交量3.5794万股，换手率0.07%，振幅3.82%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.89%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。消息层面，截至21时44分，《威廉博莱维持uniQure NV买入评级》资讯为影响Uniqure N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070221443596818d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070221443596818d36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2443795674","title":"Uniqure N.V.盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443795674","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443795674?lang=zh_cn&edition=full","pubTime":"2024-06-14 23:19","pubTimestamp":1718378378,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日23时19分，Uniqure N.V.股票出现异动，股价快速下跌5.14%。截至发稿，该股报4.98美元/股，成交量14.0386万股，换手率0.29%，振幅4.00%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.23%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614231938aef50bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614231938aef50bd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2442315849","title":"Uniqure N.V.盘中异动 急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442315849","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442315849?lang=zh_cn&edition=full","pubTime":"2024-06-11 23:28","pubTimestamp":1718119736,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日23时28分，Uniqure N.V.股票出现波动，股价大幅下跌5.01%。截至发稿，该股报5.11美元/股，成交量26.7349万股，换手率0.55%，振幅4.37%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.28%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611232856941edc73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611232856941edc73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2441534242","title":"Uniqure N.V.盘中异动 下午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441534242","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441534242?lang=zh_cn&edition=full","pubTime":"2024-06-05 01:10","pubTimestamp":1717521021,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日01时10分，Uniqure N.V.股票出现波动，股价大幅上涨5.07%。截至发稿，该股报5.60美元/股，成交量39.7613万股，换手率0.82%，振幅7.50%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.95%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。其产品和服务专注于血友病、亨廷顿病和心血管疾病。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605011021941ec507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605011021941ec507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX","QURE"],"gpt_icon":0},{"id":"2440493179","title":"Uniqure N.V.盘中异动 早盘快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440493179","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440493179?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:30","pubTimestamp":1717421436,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时30分，Uniqure N.V.股票出现波动，股价大幅拉升5.05%。截至发稿，该股报5.20美元/股，成交量1344股，换手率0.00%，振幅0.00%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为1.33%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213037af8ba6b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213037af8ba6b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2440494651","title":"Uniqure N.V.盘中异动 股价大涨7.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440494651","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440494651?lang=zh_cn&edition=full","pubTime":"2024-06-01 01:56","pubTimestamp":1717178200,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日01时56分，Uniqure N.V.股票出现异动，股价大幅拉升7.05%。截至发稿，该股报5.01美元/股，成交量22.9249万股，换手率0.47%，振幅4.91%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.39%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015641aef2d1e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015641aef2d1e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2434869583","title":"Uniqure N.V.盘中异动 大幅跳水5.03%报4.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434869583","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434869583?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:25","pubTimestamp":1715358321,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日00时25分，Uniqure N.V.股票出现异动，股价急速下挫5.03%。截至发稿，该股报4.82美元/股，成交量30.005万股，换手率0.62%，振幅6.27%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.05%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。该信息摘要如下：HC Wainwright & Co.：重申uniQure评级，由买入调整至买入评级, 目标价25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100252187e8729f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100252187e8729f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2434011717","title":"Uniqure N.V.盘中异动 大幅拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434011717","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434011717?lang=zh_cn&edition=full","pubTime":"2024-05-09 23:05","pubTimestamp":1715267152,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日23时05分，Uniqure N.V.股票出现波动，股价快速上涨5.11%。截至发稿，该股报5.14美元/股，成交量14.19万股，换手率0.29%，振幅5.93%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.66%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。消息层面，截至23时05分，《HC Wainwright & Co.：重申uniQure评级，由买入调整至买入评级, 目标价25.00美元。》资讯为影响Uniqure N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092305537a59048e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092305537a59048e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2434677011","title":"HC Wainwright & Co.：重申uniQure(QURE.US)评级，由买入调整至买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434677011","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434677011?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:15","pubTimestamp":1715195718,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申uniQure(QURE.US)评级，由买入调整至买入评级, 目标价25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090315188ae9a761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090315188ae9a761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE"],"gpt_icon":0},{"id":"2432058239","title":"Uniqure N.V.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432058239","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432058239?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:54","pubTimestamp":1714744442,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时54分，Uniqure N.V.股票出现波动，股价急速拉升5.34%。截至发稿，该股报4.93美元/股，成交量11.8715万股，换手率0.24%，振幅3.42%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.05%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032154037a57fbf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032154037a57fbf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE","VAXX"],"gpt_icon":0},{"id":"2432361416","title":"Uniqure N.V.盘中异动 大幅上涨5.10%报4.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432361416","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432361416?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:13","pubTimestamp":1714590804,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时13分，Uniqure N.V.股票出现异动，股价急速拉升5.10%。截至发稿，该股报4.64美元/股，成交量54.6543万股，换手率1.13%，振幅5.90%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为2.45%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020313247925a532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020313247925a532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2427754039","title":"Uniqure N.V.盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427754039","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427754039?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:22","pubTimestamp":1712949727,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时22分，Uniqure N.V.股票出现波动，股价急速下挫5.07%。截至发稿，该股报4.78美元/股，成交量74.9909万股，换手率1.57%，振幅5.17%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为1.75%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413032207861e5618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413032207861e5618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2424282421","title":"Uniqure N.V.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424282421","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424282421?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:46","pubTimestamp":1712162795,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时46分，Uniqure N.V.股票出现波动，股价急速上涨5.02%。截至发稿，该股报5.23美元/股，成交量28.3978万股，换手率0.59%，振幅5.32%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.22%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404004635791ec2e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404004635791ec2e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uniqure.com","stockEarnings":[{"period":"1week","weight":-0.163},{"period":"1month","weight":0.6612},{"period":"3month","weight":0.6053},{"period":"6month","weight":0.3496},{"period":"1year","weight":-0.239},{"period":"ytd","weight":0.1263}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"uniQure N.V.作为私人有限责任公司于2012年1月9日依照荷兰相关法律条文成立。uniQure公司在基因疗法领域是领导者，同时研发了第一个也是迄今为止唯一一个得到欧盟监管认可的基因疗法产品。通过引导治疗性蛋白基因或者通过的表达，或者通过单一管理修复缺失蛋白的表达，基因疗法向有基因或获得性疾病的患者提供长期而且潜在有效的利益。公司的第一个产品，即阿利泼金（Glybera），由于该药对脂蛋白脂酶缺乏（LPLD）患者治疗的极佳效果被欧洲委员会在2012年10月通过，上述疾病是具有潜在生命危险的孤儿代谢性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.005086},{"month":2,"riseRate":0.6,"avgChangeRate":0.087111},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.041415},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.015715},{"month":5,"riseRate":0.727273,"avgChangeRate":0.048657},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.006965},{"month":7,"riseRate":0.272727,"avgChangeRate":0.035484},{"month":8,"riseRate":0.5,"avgChangeRate":0.013497},{"month":9,"riseRate":0.2,"avgChangeRate":-0.094468},{"month":10,"riseRate":0.4,"avgChangeRate":0.040482},{"month":11,"riseRate":0.8,"avgChangeRate":0.128908},{"month":12,"riseRate":0.2,"avgChangeRate":-0.032638}],"exchange":"NASDAQ","name":"uniQure N.V.","nameEN":"uniQure NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"uniQure N.V.,QURE,uniQure N.V.股票,uniQure N.V.股票老虎,uniQure N.V.股票老虎国际,uniQure N.V.行情,uniQure N.V.股票行情,uniQure N.V.股价,uniQure N.V.股市,uniQure N.V.股票价格,uniQure N.V.股票交易,uniQure N.V.股票购买,uniQure N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}